MariMed Inc (MRMD): i dont KNow where you read that but this...

Reply Private New

Replies (3) Next 10 Prev Next

Send PM Follow Ignore

Followers	28
Posts	3098
Boards Moderated	0
Alias Born	07/08/2010

Stoquer1

Re: foti1kenobi post# 4119

Monday, 11/15/2021 5:49:33 PM

Monday, November 15, 2021 5:49:33 PM

i dont KNow where you read that but this came from the co website. The Company is maintaining full year 2021 financial guidance of $118 million in revenue and $42 million in Adjusted EBITDA.

Keep Last Read

Replies (3) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent MRMD News

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:30:47 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:05:01 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/07/2024 09:02:55 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 10:06:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 10:03:37 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/09/2023 09:11:11 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:07:54 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 10:06:50 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 11:35:02 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/30/2023 09:24:42 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/30/2023 09:17:46 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2023 10:29:20 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 06:45:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2023 09:13:09 PM

More MRMD News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover